SILVER SPRING, Md. (AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported a first-quarter loss of $494.6 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Silver Spring, Maryland-based company said it had a loss of $11.32. Earnings, adjusted for non-recurring costs and stock option expense, were $3.58 per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $2.64 per share.
The drugmaker posted revenue of $362.6 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $330.5 million.
United Therapeutics shares have declined roughly 6% since the beginning of the year. The stock has decreased nearly 7% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR